{{Rsnum
|rsid=3795958
|Gene=CCDC164
|Chromosome=2
|position=26444262
|Orientation=plus
|GMAF=0.1584
|Gene_s=CCDC164
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.2 | 17.7 | 7.1
| HCB | 53.7 | 41.2 | 5.1
| JPT | 71.7 | 25.7 | 2.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 53.7 | 41.2 | 5.1
| CHD | 51.9 | 37.0 | 11.1
| GIH | 51.5 | 40.6 | 7.9
| LWK | 0.0 | 0.0 | 0.0
| MEX | 60.3 | 39.7 | 0.0
| MKK | 94.2 | 5.8 | 0.0
| TSI | 62.7 | 33.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23319000
  |Trait=Metabolite levels (HVA)
  |Title=Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.
  |RiskAllele=G
  |Pval=2E-6
  |OR=.24
  |ORtxt=unit increase
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}